Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Brain Research
|
August 22, 1975
Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors
M D Prada, A Saner, W P Burkark, et al.
Brain Research
|
October 26, 1979
Effect of clonidine on utilization and potassium-evoked release of adrenaline in rat brain areas
B Scatton, F Pelayo, M L Dubocovich, et al.
Psychopharmacology Bulletin
|
January 1, 1985
The GABA hypothesis of depression and antidepressant drug action
G Bartholini, K G Lloyd, B Scatton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1974
Absence of degeneration of adrenergic neurons after prolonged treatment with debrisoquin
G Haeusler, H P Lorez, G Bartholini, et al.
European Journal of Pharmacology
|
June 25, 1991
Difluoromethyl ornithine protects against the neurotoxic effects of intrastriatally administered N-methyl-D-aspartate in vivo
A Porcella, D Fage, C Voltz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra
P Worms, H Depoortere, A Durand, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1990
The psychopharmacology of GABA synapses: update 1989
K G Lloyd, P Pichat, B Scatton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas
B Scatton, B Zivkovic, J Dedek, et al.
Psychopharmacology. Supplementum
|
January 1, 1985
Influence of GABA mimetics and lithium on biochemical manifestations of striatal dopamine target cell hypersensitivity
B Scatton, D Fage, A Oblin, et al.
Schweizerische Medizinische Wochenschrift
|
October 20, 1973
[Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study]
R Tissot, G Bartholini, J Constantinidis, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Brain Research
|
August 22, 1975
Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors
M D Prada, A Saner, W P Burkark, et al.
Brain Research
|
October 26, 1979
Effect of clonidine on utilization and potassium-evoked release of adrenaline in rat brain areas
B Scatton, F Pelayo, M L Dubocovich, et al.
Psychopharmacology Bulletin
|
January 1, 1985
The GABA hypothesis of depression and antidepressant drug action
G Bartholini, K G Lloyd, B Scatton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1974
Absence of degeneration of adrenergic neurons after prolonged treatment with debrisoquin
G Haeusler, H P Lorez, G Bartholini, et al.
European Journal of Pharmacology
|
June 25, 1991
Difluoromethyl ornithine protects against the neurotoxic effects of intrastriatally administered N-methyl-D-aspartate in vivo
A Porcella, D Fage, C Voltz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra
P Worms, H Depoortere, A Durand, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1990
The psychopharmacology of GABA synapses: update 1989
K G Lloyd, P Pichat, B Scatton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas
B Scatton, B Zivkovic, J Dedek, et al.
Psychopharmacology. Supplementum
|
January 1, 1985
Influence of GABA mimetics and lithium on biochemical manifestations of striatal dopamine target cell hypersensitivity
B Scatton, D Fage, A Oblin, et al.
Schweizerische Medizinische Wochenschrift
|
October 20, 1973
[Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study]
R Tissot, G Bartholini, J Constantinidis, et al.
Page
of 10